Gough SCL, Bode B, Woo V, et al
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-B and MAPK pathways via GLP-1R
These convenient, nutrient-rich shakes can help support daily nutritional intake when your regular eating pattern may be restructured as part of a balanced weight-management plan
Gradual Weight Loss and Muscle Maintenance For those using GLP-1 drugs primarily for weight loss, microdosing might offer a more gradual weight loss experience, which some individuals believe helps preserve muscle mass
To put that into perspective, a 1kg bag provides roughly 1,667 servings at 600mg daily or about 833 servings at 1,200mg daily
While these primary mechanisms don't necessarily cause fatigue directly, the downstream effectsparticularly reduced caloric intake and gastrointestinal symptomsmay contribute to feelings of tiredness in some individuals